0LSZ Stock Overview
Walgreens Boots Alliance, Inc. operates as a healthcare, pharmacy, and retail company in the United States, the United Kingdom, Germany, and internationally.
Snowflake Score | |
---|---|
Valuation | 3/6 |
Future Growth | 4/6 |
Past Performance | 1/6 |
Financial Health | 3/6 |
Dividends | 1/6 |
Walgreens Boots Alliance, Inc. Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | US$20.52 |
52 Week High | US$36.55 |
52 Week Low | US$19.68 |
Beta | 0.72 |
1 Month Change | -5.83% |
3 Month Change | -22.91% |
1 Year Change | -39.96% |
3 Year Change | -61.30% |
5 Year Change | -63.25% |
Change since IPO | -74.07% |
Recent News & Updates
Recent updates
Shareholder Returns
0LSZ | GB Consumer Retailing | GB Market | |
---|---|---|---|
7D | -0.9% | 1.8% | 2.1% |
1Y | -40.0% | 24.6% | 3.8% |
Return vs Industry: 0LSZ underperformed the UK Consumer Retailing industry which returned 24.6% over the past year.
Return vs Market: 0LSZ underperformed the UK Market which returned 3.8% over the past year.
Price Volatility
0LSZ volatility | |
---|---|
0LSZ Average Weekly Movement | 5.0% |
Consumer Retailing Industry Average Movement | 4.3% |
Market Average Movement | 4.8% |
10% most volatile stocks in GB Market | 11.2% |
10% least volatile stocks in GB Market | 2.5% |
Stable Share Price: 0LSZ's share price has been volatile over the past 3 months.
Volatility Over Time: 0LSZ's weekly volatility (5%) has been stable over the past year.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
1909 | 268,500 | Tim Wentworth | https://www.walgreensbootsalliance.com |
Walgreens Boots Alliance, Inc. operates as a healthcare, pharmacy, and retail company in the United States, the United Kingdom, Germany, and internationally. It operates through three segments: U.S. Retail Pharmacy, International, and U.S.
Walgreens Boots Alliance, Inc. Fundamentals Summary
0LSZ fundamental statistics | |
---|---|
Market cap | US$17.79b |
Earnings (TTM) | US$574.00m |
Revenue (TTM) | US$142.41b |
30.8x
P/E Ratio0.1x
P/S RatioIs 0LSZ overvalued?
See Fair Value and valuation analysisEarnings & Revenue
0LSZ income statement (TTM) | |
---|---|
Revenue | US$142.41b |
Cost of Revenue | US$115.52b |
Gross Profit | US$26.89b |
Other Expenses | US$26.32b |
Earnings | US$574.00m |
Last Reported Earnings
Nov 30, 2023
Next Earnings Date
Mar 28, 2024
Earnings per share (EPS) | 0.67 |
Gross Margin | 18.88% |
Net Profit Margin | 0.40% |
Debt/Equity Ratio | 33.3% |
How did 0LSZ perform over the long term?
See historical performance and comparison